Diagnostics

A stark new benchmark study reveals poor survival in late-stage GvHD, just as MaaT Pharma’s microbiome therapy shows dramatically better outcomes.

The Our Health Our Wellness campaign aims to close critical health disparity gaps with resources, events, and education for underserved communities.

NewBeauty's 16th annual awards spotlight 395 winners, signaling a major shift towards science-backed efficacy and holistic health in the beauty market.

Up to 14.9 million Europeans suffer from chronic wounds. A new industry white paper details the staggering cost and provides a roadmap for urgent policy reform.

A new, imageable liver cancer therapy is one step closer to patients, thanks to a strategic partnership securing a vital US-based medical isotope supply.

Amid rising rabies deaths in Sarawak, an international summit aims to unite Asia in the fight against the fatal disease. Can collaboration turn the tide?

A shocking new installation reveals a dangerous blind spot: your car isn't protecting you from the sun's harmful rays. Here's what you need to know.

The diagnostics firm posts strong thyroid growth after a strategic shift, but a one-time tax adjustment inflates its impressive 2025 bottom line.

Sangamo pushes a promising Fabry disease therapy toward the FDA while a cash crunch forces a strategic pivot to brain-targeting neurological cures.

Agena Bioscience's new test helps labs align with updated ACMG recommendations for cystic fibrosis, aiming for more equitable and efficient carrier screening.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.

Roche has received FDA clearance for two new high-speed diagnostic units designed to alleviate lab staff shortages and dramatically increase testing capacity.

After a major capital overhaul, PAVmed pivots to growth, advancing cancer diagnostics, remote monitoring, and a relaunched device portfolio.

Over 3.5 million Africans suffer from psoriasis with little support. A historic forum in Nairobi aims to shatter the silence and forge a new path for care.

A Denver clinic now offers Therapeutic Plasma Exchange for anti-aging. But does the science back up the high-cost promise of turning back the clock?

A landmark partnership is scaling a 'one-drug, many-diseases' therapy, revealing how logistics, not just labs, are key to the future of medicine.

A gene expression test is changing melanoma care by providing risk data beyond traditional staging, enabling more tailored treatment for patients.

A major investment aims to develop biomarkers for TAND, the neuropsychiatric challenges affecting most with TSC, offering new hope for families.

Biocon names 30-year veteran Shreehas Tambe as its new CEO, consolidating its biosimilar and generics arms to create a global biopharma powerhouse.

A French biopharma's leap in synthetic lipid production de-risks its lead drug, eyes a vast sepsis market, and creates new commercial avenues.